Risdiplam-d4

• CAT Number: S000119
• Molecular Formula: C22H19D4N7O
• Molecular Weight: 405.49
• Purity: ≥95%
• Target: DNA/RNA Synthesis
• IUPAC Name: 2-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)-7-(5,5,8,8-tetradeuterio-4,7-diazaspiro[2.5]octan-7-yl)pyrido[1,2-a]pyrimidin-4-one
• InChI: InChI=1S/C22H23N7O/c1-14-9-18(26-29-11-15(2)24-21(14)29)17-10-20(30)28-12-16(3-4-19(28)25-17)27-8-7-23-22(13-27)5-6-22/h3-4,9-12,23H,5-8,13H2,1-2H3/i7D2,13D2
• InChIKey: ASKZRYGFUPSJPN-YCCQUKDNSA-N
• SMILES: [2H]C1(CN(C(C2(N1)CC2)([2H])[2H])C3=CN4C(=NC(=CC4=O)C5=NN6C=C(N=C6C(=C5)C)C)C=C3)[2H]

Risdiplam-d4, a high-quality pharmaceutical research compound designed for advanced studies in neuromuscular and genetic disorder research. As a deuterated analog of Risdiplam, it offers enhanced stability and improved pharmacokinetic properties. Risdiplam-d4 is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel therapies for spinal muscular atrophy (SMA) and other neuromuscular disorders. Trusted by leading laboratories, Risdiplam-d4 is your go-to solution for cutting-edge genetic disorder research. Unlock new possibilities in SMA and neuromuscular treatment with Risdiplam-d4, where innovation meets reliability.